NCT01611805View on ClinicalTrials.gov

Japanese Phase I of GSK1605786

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 22, 2010

Primary Completion Date

October 6, 2010

Study Completion Date

October 6, 2010

Conditions

Crohn's Disease

Interventions

DRUG

GSK1605786

Opaque Swedish orange body and cap.

DRUG

GSK1605786 Placebo

Opaque Swedish orange body and cap.

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01611805 - Japanese Phase I of GSK1605786 | Biotech Hunter | Biotech Hunter